alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › neuroimaging-biomarkers

neuroimaging-biomarkers

3 studies tagged neuroimaging-biomarkers, dated 2017-05-02 to 2024-05-16. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients 2024-05-16
  2. Transfer Learning for Alzheimer's Disease through Neuroimaging Biomarkers: A Systematic Review 2021-10-31
  3. Assessment of cerebral microbleeds by susceptibility-weighted imaging in Alzheimer's disease patients: A neuroimaging biomarker of the disease 2017-05-02

Studies

3 studies carry this tag.

Date range

2017 to 2024

Top journals

  • Alzheimer's research & therapy 1
  • Sensors (Basel, Switzerland) 1
  • The neuroradiology journal 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Alzheimer's research & therapy 2024-05-16 Biomarkers

    Plasma NfL and GFAP predict cognitive decline in a similar manner to traditional imaging techniques in amyloid-positive MCI patients.

  2. Transfer Learning for Alzheimer's Disease through Neuroimaging Biomarkers: A Systematic Review

    ✓ Peer-reviewed alzhub usefulness score 74 out of 100. Sensors (Basel, Switzerland) 2021-10-31 Brain scans and imaging

    Alzheimer's disease (AD) is a remarkable challenge for healthcare in the 21st century.

  3. Assessment of cerebral microbleeds by susceptibility-weighted imaging in Alzheimer's disease patients: A neuroimaging biomarker of the disease

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. The neuroradiology journal 2017-05-02 Biomarkers

    Lobar distribution of cerebral microbleeds is associated with Alzheimer's disease and the number of lobar cerebral microbleeds directly correlates with cerebrospinal fluid amyloid-beta and phosphorylated tau 181 protein levels and with the cognitive decline of Alzheimer's disease patients.

All topic tags with their study counts